Copyright
©The Author(s) 2021.
World J Clin Cases. Dec 26, 2021; 9(36): 11285-11299
Published online Dec 26, 2021. doi: 10.12998/wjcc.v9.i36.11285
Published online Dec 26, 2021. doi: 10.12998/wjcc.v9.i36.11285
Table 1 Variables collected at baseline and during follow-up visits
Variable | Baseline | Follow-up |
Demographic data | ||
Date of birth | X | - |
Gender | X | - |
Smoking habit | X | - |
Disease data | ||
Date of diagnosis | X | - |
IBD type (Crohn’s disease, ulcerative colitis) | X | - |
Montreal classification | X | - |
Type of fistula (perianal, entero-enteral, enterovesical, enterovaginal, enterocutaneous, other) | X | - |
Intra-intestinal complications (yes or no) | X | - |
Extraintestinal complications (dermatological, osseous, optical, hepatic) | X | - |
Harvey-Bradshaw index | X | X |
Crohn’s disease activity index | X | X |
Partial Mayo Score | X | X |
Truelove-Witts severity index | X | X |
Laboratory analysis | ||
C-reactive protein | X | X |
Erythrocyte sedimentation rate | X | X |
Hemoglobin | X | X |
Calprotectin | X | X |
CT-P13 trough levels and antibodiesx | - | X |
Imaging tests | ||
Disease severity and lesion location according to endoscopy result (mild, moderate, severe) | X | X |
Disease severity and lesion location according to magnetic resonance enterography result (mild, moderate, severe, fibrotic stenosis) | X | X |
Treatment data | ||
Current treatments (mesalazine, cortisone, AZA/6-MP, MTX) | X | X |
Previous treatments (mesalazine, corticosteroids, AZA/6-MP, MTX, infliximab, adalimumab) | X | - |
Reasons to start treatment with CT-P13 (corticosteroid dependence, corticosteroid resistance, failure of AZA/6-MP, perianal disease/fistula, start of severe illness) | X | - |
Clinical situation | ||
Active clinical disease | X | X |
Clinical remission | X | X |
Clinical response | - | X |
- Citation: Huguet JM, Cortés X, Bosca-Watts MM, Aguas M, Maroto N, Martí L, Amorós C, Paredes JM. Real-world data on the infliximab biosimilar CT-P13 (Remsima®) in inflammatory bowel disease. World J Clin Cases 2021; 9(36): 11285-11299
- URL: https://www.wjgnet.com/2307-8960/full/v9/i36/11285.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i36.11285